13F Holdings
中文EN

MMM 3M CO

Surgical & Medical Instruments & Apparatus · NYSE · SEC CIK 66740 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY1.7%
TTM net income YoY4.0%
TTM EPS YoY7.0%
Revenue 3-yr CAGR-1.8%
Net income 3-yr CAGR—

Margins

Gross margin39.5%
Operating margin18.8%
Net margin14.0%
FCF margin10.6%
EBITDA margin24.4%

Returns

ROE80.8%
ROA9.2%
ROIC (approx.)28.5%
Asset turnover0.65x

Leverage & solvency

Liabilities / assets87.0%
Debt / equity3.63x
Current ratio1.41x
Interest coverage5.54x

Cash quality & payout

Operating cash flow / net income1.03x
Accruals ratio-0.2%
Payout ratio45.3%
Capex / revenue3.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$24.95B$24.57B$24.61B$26.16B$35.35B
Cost of revenue$14.99B$14.45B$14.98B$15.85B$18.80B
Gross profit$9.96B$10.13B$9.63B$10.31B$16.56B
R&D expense—$700.00M$700.00M$800.00M$1.20B
SG&A expense$4.00B$4.22B$19.20B$7.23B$7.20B
Operating income$4.63B$4.82B-$10.69B$4.37B$7.37B
Interest expense$946.00M$1.19B$941.00M$462.00M$488.00M
Pretax income$4.21B$4.82B-$11.27B$4.20B$7.20B
Income tax$1.00B$804.00M-$2.87B$188.00M$1.28B
Net income$3.25B$4.17B-$7.00B$5.78B$5.92B
EBITDA$5.94B$6.18B-$8.70B$6.20B$9.28B
EPS (basic)6.057.58-12.6310.2110.23
EPS (diluted)6.007.55-12.6310.1810.12
Dividends declared per share2.923.616.005.965.92
Weighted avg. shares (diluted)541.30M552.40M553.90M567.60M585.30M
Balance sheet
Cash & equivalents$5.24B$5.60B$5.93B$3.65B$4.56B
Receivables$3.53B$3.19B$3.60B$4.53B$4.66B
Inventory$3.66B$3.70B$3.94B$5.37B$4.99B
Current assets$16.39B$15.88B$16.38B$14.69B$15.40B
PP&E, net$7.10B$7.39B$7.69B$9.18B$9.43B
Goodwill$6.42B$6.28B$6.38B$6.34B$13.49B
Intangibles$1.10B$1.21B$1.32B$4.70B$5.29B
Total assets$37.73B$39.87B$50.58B$46.45B$47.07B
Current liabilities$9.60B$11.26B$15.30B$9.52B$9.04B
Short-term debt$1.67B$1.92B$2.95B$1.94B$1.31B
Long-term debt$10.93B$11.12B$13.09B$14.00B$16.06B
Total debt$12.60B$13.04B$16.04B$15.94B$17.36B
Total liabilities$32.99B$35.97B$45.71B$31.68B$31.95B
Shareholders' equity$4.70B$3.84B$4.81B$14.72B$15.05B
Net debt$7.37B$7.44B$10.10B$12.28B$12.80B
Shares outstanding530.28M539.47M552.58M549.25M571.85M
Cash flow statement
Operating cash flow$2.31B$1.82B$6.68B$5.59B$7.45B
Capital expenditure$910.00M$1.18B$1.61B$1.75B$1.60B
Free cash flow$1.40B$638.00M$5.07B$3.84B$5.85B
Investing cash flow$1.35B-$3.21B-$1.21B-$1.05B-$1.32B
Financing cash flow-$4.02B$1.10B-$3.15B-$5.35B-$6.14B
Depreciation & amortization$1.31B$1.36B$1.99B$1.83B$1.92B
Stock-based compensation$225.00M$289.00M$274.00M$263.00M$274.00M
Dividends paid$1.56B$1.98B$3.31B$3.37B$3.42B
Share buybacks$3.25B$1.80B$33.00M$1.46B$2.20B

Free plan shows the latest 5 periods; Pro shows all 19 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.